"Quinax", instructions for use characterizes as a metabolic drug used in the treatment of various forms of cataracts. The main active ingredient of this drug is azapentacene, under the same name the drug is registered in the INN registry. The action of the drug is based on the ability of azapentacene to dissolve opaque formations in the lens of the eye.
The drug "Quinax" is a 0.015% ophthalmic sterile solution (drops), which is supplied in special dropper bottles of 15 milliliters.
The composition of the drug includes, in addition to azapentacene, the following substances: purified water, thiomersal, methylparaben, propylparaben, boric acid.
The action of the drug Quinax, instructions for use are described as follows. Azapentacene has properties that allow it to protect the lens proteins containing sulfhydryl groups from oxidation. It also activates the process of resorption of opaque local neoplasms and complexes that occur in the lens. The drug activates those proteolytic enzymes that are in front of the eye chamber. The drug is able to inhibit the formation of quinoid compounds and, thereby, reduce the degree of their effect on the lens proteins.
Pharmacokinetic properties, in particular - systemic absorption of the drug "Quinax", the instructions for use are characterized as low in the case of topical use of the drug.
Indications for use are such forms of cataracts as senile and congenital. The medicine is also used in the treatment of traumatic and congenital forms of cataract.
The drug "Quinax" instruction recommends instilling in the conjunctival sac of the eye for a long period of time. The recommended dose is 2 drops. Instillation must be carried out three to five times during the day. When an improvement in vision occurs, without the recommendation of a doctor, the use of the drug should not be interrupted.
The main factors of contraindications when taking the drug are the following. The use of the drug is not recommended for patients who have established individual hypersensitivity to its components. The instruction stipulates pregnancy and breast-feeding periods of infants as contraindications to use, although there is no necessary data on this problem. Therefore, during these periods, the expected effect of the use of the drug and the degree of risk of the formation of side effects should be correlated.
As such, Quinax eye drops can cause the development of conjunctivitis, burning during direct administration of the drug, itching after instillation, and other allergic reactions. As already noted, the drug is designed for prolonged use, and they should not interrupt treatment, since the therapeutic effect can be lost.
Those patients who use contact lenses for continuous wear should take the medicine only with the lenses removed, after which they can be installed in no less than 15 minutes. Quinax Drops, the instructions for use recommend with extreme caution to use for the treatment of children, because the necessary experience of such treatment is not available.
The rules for using a dropper bottle for instillation should be followed: first of all, it must be tightly closed after each dose of the medicine, because when light enters, the active substance - azapentacene is destroyed. In addition, after opening the dropper bottle, the drug retains its medicinal properties for four weeks.
You should not sit behind the wheel after taking the drug.
The instruction recommends storing the product at a temperature in the range of 8-25 C, in a dark place. The drug is sold in pharmacies by prescription.